216
Views
2
CrossRef citations to date
0
Altmetric
Original Scientific Contributions

Delayed resolution of amitriptyline toxicity secondary to CYP2D6 deficiency

ORCID Icon, ORCID Icon, &
Pages 825-827 | Received 28 Aug 2018, Accepted 29 Dec 2018, Published online: 19 Feb 2019

References

  • Olesen OV, Linnet K. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes. Pharmacology. 1997;55:235–243.
  • Hicks JK, Swen JJ, Thorn CF, et al. Clinical pharmacogenetics implementation consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther. 2013;93:402–408.
  • Acosta D, Ramos K. Cardiotoxicity of tricyclic antidepressants in primary cultures of rat myocardial cells. J Toxicol Environ Health. 1984;14:137–143.
  • Bijl MJ, Visser LE, Hofman A, et al. Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants. Br J Clin Pharmacol. 2008;65:558–564.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.